Limb-girdle muscular dystrophy 2N, POMT2 gene mutation (Q86088)

From determinar.ia.br - Determine suas informações
Revision as of 11:27, 15 August 2026 by Determinaradmin (talk | contribs) (‎Changed label, description and/or aliases in pt-br, en)
Limb-girdle muscular dystrophy-dystroglycanopathy (type C2; MDDGC2), previously designated limb-girdle muscular dystrophy type 2N (LGMD2N), is caused by homozygous or compound heterozygous mutation in the POMT2 gene on chromosome 14q24.3. It is an autosomal recessive muscular dystrophy with onset after ambulation is achieved. Cognition is normal. It is part of a group of similar disorders resulting from defective glycosylation of alpha-dystroglycan, collectively known as dystroglycanopathies.
Language Label Description Also known as
default for all languages
ID_1682388047
    English
    Limb-girdle muscular dystrophy 2N, POMT2 gene mutation
    Limb-girdle muscular dystrophy-dystroglycanopathy (type C2; MDDGC2), previously designated limb-girdle muscular dystrophy type 2N (LGMD2N), is caused by homozygous or compound heterozygous mutation in the POMT2 gene on chromosome 14q24.3. It is an autosomal recessive muscular dystrophy with onset after ambulation is achieved. Cognition is normal. It is part of a group of similar disorders resulting from defective glycosylation of alpha-dystroglycan, collectively known as dystroglycanopathies.

      Statements